PhoenixBio Co (TSE:6190) FFO


TSE:6190 PhoenixBio Co Ltd TSE:6190
57 GF Score
Price 円330.00
GF Value 円361.16
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:6190
57GF Score
PhoenixBio Co Ltd TSE:6190
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円330.00 is trading 8.6% below its estimated GF Value™ of 円361.16. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • FFO:
  • GF Value™: 円361.16 vs. price of 円330.00 (8.6% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
57GF Score

Get the complete analysis for TSE:6190

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円330.00
Price
円361.16
GF Value